Overview

Malignant Pleural Effusion With ZD6474

Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn the effect of ZD6474 on the amount of time between placement of an indwelling pleural catheter and the catheter's removal in patients with malignant pleural effusion. This study will also look at the effect that ZD6474 has on tumor cells, biological characteristics of cells in the body, rate of fluid build-up around the lungs, tumor size, and thickness of blood vessels. The effect that this drug has on quality of life and shortness of breath will also be examined.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
AstraZeneca
United States Department of Defense
Treatments:
Endothelial Growth Factors
Mitogens